0001209191-16-126674.txt : 20160608
0001209191-16-126674.hdr.sgml : 20160608
20160608203417
ACCESSION NUMBER: 0001209191-16-126674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160607
FILED AS OF DATE: 20160608
DATE AS OF CHANGE: 20160608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dimension Therapeutics, Inc.
CENTRAL INDEX KEY: 0001592288
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463942159
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-401-0011
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clark K. Reed
CENTRAL INDEX KEY: 0001653061
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37601
FILM NUMBER: 161704771
MAIL ADDRESS:
STREET 1: C/O DIMENSION THERAPEUTICS, INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-07
0
0001592288
Dimension Therapeutics, Inc.
DMTX
0001653061
Clark K. Reed
C/O DIMENSION THERAPEUTICS, INC.
840 MEMORIAL DRIVE, 4TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
SVP of Pharmaceutical Develop
Common Stock
2016-06-07
4
M
0
5000
0.38
A
5000
D
Common Stock
2016-06-07
4
S
0
5000
10.00
D
0
D
Stock Option (Right to Buy)
0.38
2016-06-07
4
M
0
5000
0.00
D
2024-04-21
Common Stock
5000
114739
D
This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This stock option vests over four (4) years beginning on April 1, 2014, at a rate of twenty-five percent (25%) after 12 months, and in thirty-six (36) equal monthly installments thereafter.
/s/ Jean Franchi, as Attorney-in-Fact for K. Reed Clark
2016-06-08